JP Patent

JP2726563B2 — 置換ベンジル要素を含むトリアゾールアンギオテンシン▲ｉｉ▼拮抗物質

Assigned to Merck and Co Inc · Expires 1998-03-11 · 28y expired

What this patent protects

Patent listed against Trulance.

Drugs covered by this patent

Patent Metadata

Patent number
JP2726563B2
Jurisdiction
JP
Classification
—
Expires
1998-03-11
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.